All-trans retinoic acid and gemtuzumab ozogamicin as adjunct to high-dose cytarabine-based salvage therapy in primary refractory acute myeloid leukemia: Results of AMLSG 05-04 trial
Journal title abbreviation:
Blood
Year:
2007
Journal volume:
110
Journal issue:
11
Pages contribution:
544A-544A
Language:
eng
Print-ISSN:
0006-4971
TUM Institution:
III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie)